CCM
CVS icon

Cadence Capital Management’s CVS Health CVS Stock Holding History

Cadence Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$2.09M Sell
35,855
-9,503
-21% -$591K 0.51% 53
2020
Q2 		$2.95M Buy
45,358
+9,636
+27% +$607K 0.43% 46
2020
Q1 		$2.12M Buy
35,722
+3,423
+11% +$229K 0.36% 69
2019
Q4 		$2.4M Buy
32,299
+2,036
+7% +$143K 0.26% 90
2019
Q3 		$1.91M Sell
30,263
-2,030
-6% -$120K 0.27% 151
2019
Q2 		$1.76M Buy
32,293
+11,876
+58% +$640K 0.18% 181
2019
Q1 		$1.1M Sell
20,417
-1,338
-6% -$82.6K 0.1% 266
2018
Q4 		$1.43M Sell
21,755
-92,024
-81% -$6.87M 0.14% 208
2018
Q3 		$8.96M Buy
113,779
+40,855
+56% +$2.92M 0.48% 57
2018
Q2 		$4.69M Sell
72,924
-65,307
-47% -$4.3M 0.28% 90
2018
Q1 		$8.6M Buy
138,231
+44,550
+48% +$3.2M 0.56% 47
2017
Q4 		$6.79M Sell
93,681
-51,614
-36% -$3.75M 0.43% 65
2017
Q3 		$11.8M Sell
145,295
-15,336
-10% -$1.21M 0.74% 35
2017
Q2 		$12.9M Buy
160,631
+1,835
+1% +$145K 0.9% 12
2017
Q1 		$12.5M Buy
158,796
+139,330
+716% +$11.1M 0.86% 27
2016
Q4 		$1.54M Buy
19,466
+179
+0.9% +$14.5K 0.11% 238
2016
Q3 		$1.72M Sell
19,287
-801
-4% -$75.6K 0.13% 204
2016
Q2 		$1.92M Sell
20,088
-332
-2% -$33.1K 0.15% 173
2016
Q1 		$2.12M Sell
20,420
-659
-3% -$64.1K 0.15% 168
2015
Q4 		$2.06M Sell
21,079
-1,447
-6% -$142K 0.14% 175
2015
Q3 		$2.17M Sell
22,526
-1,840
-8% -$193K 0.15% 163
2015
Q2 		$2.56M Sell
24,366
-253
-1% -$25.9K 0.14% 181
2015
Q1 		$2.54M Sell
24,619
-1,095
-4% -$111K 0.16% 182
2014
Q4 		$2.48M Sell
25,714
-38,480
-60% -$3.39M 0.14% 196
2014
Q3 		$5.11M Sell
64,194
-10,140
-14% -$799K 0.27% 111
2014
Q2 		$5.6M Sell
74,334
-26,110
-26% -$1.97M 0.27% 119
2014
Q1 		$7.52M Sell
100,444
-33,960
-25% -$2.4M 0.32% 83
2013
Q4 		$9.62M Sell
134,404
-20,680
-13% -$1.33M 0.36% 67
2013
Q3 		$8.8M Buy
155,084
+22,160
+17% +$1.32M 0.3% 125
2013
Q2 		$7.6M Buy
+132,924
New +$7.7M 0.36% 139

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cadence Capital Management's CVS Position: Q3 2020 in Review

Cadence Capital Management reduced its CVS Health (CVS) stake by 21% in Q3 2020, selling an estimated $591K and leaving 35,855 shares worth $2.09M. The position accounts for 0.51% of the portfolio, ranked #53.

Cadence Capital Management first reported a position in CVS in Q2 2013 and has held it in 30 quarters since. The position peaked at $12.9M in Q2 2017. 1,815 funds tracked by Wall St. Rank hold CVS as of Q3 2020.

  • Cadence Capital Management held 35,855 shares of CVS Health worth $2.09M as of Q3 2020.
  • Cadence Capital Management sold 9,503 CVS Health shares in Q3 2020, an estimated $591K.
  • CVS Health made up 0.51% of Cadence Capital Management's portfolio in Q3 2020, its #53 holding.
  • Cadence Capital Management first reported a position in CVS Health in Q2 2013 and has held it in 30 quarters since.
  • Cadence Capital Management's CVS Health position peaked at $12.9M in Q2 2017.
  • 1,815 funds tracked by Wall St. Rank held CVS Health as of Q3 2020.

Based on Cadence Capital Management's 13F filing for Q3 2020, filed 16 Oct 2020.